LT3240895T - Kompozicijos ir būdai, skirti baltymų glikozilinimui - Google Patents
Kompozicijos ir būdai, skirti baltymų glikozilinimuiInfo
- Publication number
- LT3240895T LT3240895T LTEPPCT/EP2015/081229T LT15081229T LT3240895T LT 3240895 T LT3240895 T LT 3240895T LT 15081229 T LT15081229 T LT 15081229T LT 3240895 T LT3240895 T LT 3240895T
- Authority
- LT
- Lithuania
- Prior art keywords
- compositions
- methods
- protein glycosylation
- glycosylation
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462097975P | 2014-12-30 | 2014-12-30 | |
| US201462098071P | 2014-12-30 | 2014-12-30 | |
| PCT/EP2015/081229 WO2016107818A1 (en) | 2014-12-30 | 2015-12-24 | Compositions and methods for protein glycosylation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3240895T true LT3240895T (lt) | 2022-04-11 |
Family
ID=55080101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/EP2015/081229T LT3240895T (lt) | 2014-12-30 | 2015-12-24 | Kompozicijos ir būdai, skirti baltymų glikozilinimui |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US10150952B2 (lt) |
| EP (2) | EP4043561A1 (lt) |
| JP (1) | JP6850724B2 (lt) |
| CN (1) | CN107614679A (lt) |
| BE (1) | BE1022998B1 (lt) |
| BR (1) | BR112017014031B1 (lt) |
| CA (1) | CA2971653A1 (lt) |
| DK (1) | DK3240895T3 (lt) |
| ES (1) | ES2907211T3 (lt) |
| HR (1) | HRP20220500T1 (lt) |
| HU (1) | HUE057726T2 (lt) |
| LT (1) | LT3240895T (lt) |
| MX (1) | MX2017008817A (lt) |
| PL (1) | PL3240895T3 (lt) |
| PT (1) | PT3240895T (lt) |
| SI (1) | SI3240895T1 (lt) |
| WO (2) | WO2016107818A1 (lt) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2945651T (pt) | 2013-01-17 | 2018-06-12 | Arsanis Biosciences Gmbh | Anticorpo específico para mdr e. coli |
| FI3110441T3 (fi) | 2014-02-24 | 2024-05-06 | Glaxosmithkline Biologicals S A | Uusi polysakkaridi ja sen käyttöjä |
| HUE057726T2 (hu) | 2014-12-30 | 2022-06-28 | Glaxosmithkline Biologicals Sa | Fehérje glikozilálására szolgáló készítmények és módszerek |
| AU2016224006B8 (en) | 2015-02-26 | 2020-03-19 | Vaxnewmo Llc | Acinetobacter O-oligosaccharyltransferases and uses thereof |
| TWI715617B (zh) | 2015-08-24 | 2021-01-11 | 比利時商葛蘭素史密斯克藍生物品公司 | 對抗腸道外病原性大腸桿菌之免疫保護之方法及組合物 |
| AR109621A1 (es) | 2016-10-24 | 2018-12-26 | Janssen Pharmaceuticals Inc | Formulaciones de vacunas contra glucoconjugados de expec |
| GB201704117D0 (en) * | 2017-03-15 | 2017-04-26 | London School Hygiene & Tropical Medicine | Oligosaccharyl Transferase polypeptide |
| GB201721582D0 (en) | 2017-12-21 | 2018-02-07 | Glaxosmithkline Biologicals Sa | S aureus antigens and immunogenic compositions |
| GB201721576D0 (en) | 2017-12-21 | 2018-02-07 | Glaxosmithkline Biologicals Sa | Hla antigens and glycoconjugates thereof |
| US11932670B2 (en) | 2018-06-16 | 2024-03-19 | Vaxnewmo Llc | Glycosylated ComP pilin variants, methods of making and uses thereof |
| AU2019404924A1 (en) * | 2018-12-21 | 2021-07-08 | Vaxnewmo Llc | O-linked glycosylation recognition motifs |
| HUE063875T2 (hu) * | 2019-03-18 | 2024-02-28 | Janssen Pharmaceuticals Inc | Eljárások E. coli O-antigén poliszacharidok biokonjugátumainak elõállítására, ezek készítményei és felhasználásuk módszerei |
| MA55364A (fr) | 2019-03-18 | 2022-01-26 | Glaxosmithkline Biologicals Sa | Bioconjugués d'antigènes polysaccharidiques o d'e. coli, procédés de production de ces derniers, et méthodes d'utilisation de ces derniers |
| EP3770269A1 (en) | 2019-07-23 | 2021-01-27 | GlaxoSmithKline Biologicals S.A. | Quantification of bioconjugate glycosylation |
| US20220403347A1 (en) * | 2019-08-09 | 2022-12-22 | Glaxosmithkline Biologicals S.A. | Mutated pglb oligosaccharyltransferase enzymes |
| EP3777884A1 (en) | 2019-08-15 | 2021-02-17 | GlaxoSmithKline Biologicals S.A. | Immunogenic composition |
| CN110910960B (zh) * | 2019-11-30 | 2022-07-08 | 浙江天科高新技术发展有限公司 | 一种鲍曼不动杆菌分子血清型快速分析方法 |
| MX2023003169A (es) | 2020-09-17 | 2023-03-27 | Janssen Pharmaceuticals Inc | Composiciones de vacunas multivalentes y usos de las mismas. |
| WO2022171679A2 (en) * | 2021-02-11 | 2022-08-18 | Glaxosmithkline Biologicals Sa | Protein |
| EP4313135A1 (en) | 2021-04-01 | 2024-02-07 | Janssen Pharmaceuticals, Inc. | Production of e. coli o18 bioconjugates |
| WO2023118033A1 (en) | 2021-12-22 | 2023-06-29 | Glaxosmithkline Biologicals Sa | Vaccine |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2853600B1 (en) * | 2005-05-11 | 2018-09-19 | ETH Zürich | Recombinant N-glycosylated proteins from procaryotic cells |
| KR101589554B1 (ko) * | 2008-01-03 | 2016-02-01 | 코넬 리서치 파운데이션 인코포레이티드 | 원핵생물에서의 글리코실화 단백질 발현 |
| EP3427749A1 (en) * | 2008-02-20 | 2019-01-16 | GlaxoSmithKline Biologicals SA | Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells |
| WO2011062615A1 (en) * | 2009-11-19 | 2011-05-26 | Glycovaxyn Ag | Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells |
| EP2566507B1 (en) | 2010-05-06 | 2017-11-22 | GlaxoSmithKline Biologicals SA | Capsular gram-positive bacteria bioconjugate vaccines |
| WO2013067523A1 (en) * | 2011-11-04 | 2013-05-10 | Cornell University | A prokaryote-based cell-free system for the synthesis of glycoproteins |
| WO2014111724A1 (en) * | 2013-01-18 | 2014-07-24 | London School Of Hygiene And Tropical Medicine | Glycosylation method |
| HUE057726T2 (hu) | 2014-12-30 | 2022-06-28 | Glaxosmithkline Biologicals Sa | Fehérje glikozilálására szolgáló készítmények és módszerek |
| GB201704117D0 (en) * | 2017-03-15 | 2017-04-26 | London School Hygiene & Tropical Medicine | Oligosaccharyl Transferase polypeptide |
-
2015
- 2015-12-24 HU HUE15822948A patent/HUE057726T2/hu unknown
- 2015-12-24 SI SI201531794T patent/SI3240895T1/sl unknown
- 2015-12-24 JP JP2017534795A patent/JP6850724B2/ja active Active
- 2015-12-24 MX MX2017008817A patent/MX2017008817A/es unknown
- 2015-12-24 LT LTEPPCT/EP2015/081229T patent/LT3240895T/lt unknown
- 2015-12-24 ES ES15822948T patent/ES2907211T3/es active Active
- 2015-12-24 BR BR112017014031-4A patent/BR112017014031B1/pt active IP Right Grant
- 2015-12-24 PT PT158229484T patent/PT3240895T/pt unknown
- 2015-12-24 US US15/540,690 patent/US10150952B2/en active Active
- 2015-12-24 CA CA2971653A patent/CA2971653A1/en active Pending
- 2015-12-24 DK DK15822948.4T patent/DK3240895T3/da active
- 2015-12-24 CN CN201580077147.3A patent/CN107614679A/zh active Pending
- 2015-12-24 EP EP22152503.3A patent/EP4043561A1/en active Pending
- 2015-12-24 PL PL15822948T patent/PL3240895T3/pl unknown
- 2015-12-24 EP EP15822948.4A patent/EP3240895B1/en active Active
- 2015-12-24 WO PCT/EP2015/081229 patent/WO2016107818A1/en active Application Filing
- 2015-12-24 BE BE2015/5846A patent/BE1022998B1/fr not_active IP Right Cessation
- 2015-12-24 HR HRP20220500TT patent/HRP20220500T1/hr unknown
- 2015-12-24 WO PCT/EP2015/081230 patent/WO2016107819A1/en active Application Filing
-
2018
- 2018-11-01 US US16/177,562 patent/US10577592B2/en active Active
-
2020
- 2020-02-10 US US16/785,819 patent/US11015177B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20200181586A1 (en) | 2020-06-11 |
| WO2016107818A1 (en) | 2016-07-07 |
| US20190078064A1 (en) | 2019-03-14 |
| HRP20220500T1 (hr) | 2022-06-10 |
| US20180002679A1 (en) | 2018-01-04 |
| SI3240895T1 (sl) | 2022-04-29 |
| PT3240895T (pt) | 2022-03-02 |
| EP3240895B1 (en) | 2022-01-26 |
| BR112017014031B1 (pt) | 2023-11-07 |
| US10577592B2 (en) | 2020-03-03 |
| HUE057726T2 (hu) | 2022-06-28 |
| DK3240895T3 (da) | 2022-04-11 |
| PL3240895T3 (pl) | 2022-05-02 |
| BE1022998B1 (fr) | 2016-10-28 |
| US10150952B2 (en) | 2018-12-11 |
| JP2018500912A (ja) | 2018-01-18 |
| JP6850724B2 (ja) | 2021-03-31 |
| ES2907211T3 (es) | 2022-04-22 |
| WO2016107818A8 (en) | 2017-08-31 |
| BE1022998A1 (fr) | 2016-10-28 |
| EP4043561A1 (en) | 2022-08-17 |
| CN107614679A (zh) | 2018-01-19 |
| BR112017014031A2 (pt) | 2018-01-16 |
| MX2017008817A (es) | 2017-10-24 |
| WO2016107819A1 (en) | 2016-07-07 |
| EP3240895A1 (en) | 2017-11-08 |
| CA2971653A1 (en) | 2016-07-07 |
| US11015177B2 (en) | 2021-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1257295A1 (zh) | 用於免疫腫瘤學的組合物和方法 | |
| IL262321A (en) | Preparations and methods for selective protein expression | |
| SI3240895T1 (sl) | Sestavki in postopki za glikozilacijo proteinov | |
| HK1244185A1 (zh) | 用於生成卵清蛋白的方法和組合物 | |
| GB2546350B (en) | Compositions and methods | |
| HK1253306A1 (zh) | 抗ntb-a抗體及相關組合物和方法 | |
| GB2535253B (en) | Compositions and methods | |
| GB201502305D0 (en) | Protein | |
| GB201502306D0 (en) | Protein | |
| IL250902A0 (en) | Anti-met antibodies and preparations | |
| SG11201704010UA (en) | Fibroin-derived protein composition | |
| GB201718876D0 (en) | Antithrombin-heparin compositions and methods | |
| IL246879A0 (en) | Preparations of Epilimod and methods of using them | |
| HK1245158A1 (zh) | 阿吡莫德組合物及其使用方法 | |
| HUE050893T2 (hu) | Protein | |
| GB201415344D0 (en) | Protein | |
| PL3099793T3 (pl) | Białko | |
| GB201512996D0 (en) | Compositions and methods | |
| GB201522610D0 (en) | Protein | |
| GB201514413D0 (en) | Compositions and methods | |
| GB201402915D0 (en) | Compositions and methods | |
| IL256261B (en) | Hide1 compositions and methods | |
| GB201522554D0 (en) | Methods and compositions | |
| GB201518167D0 (en) | Methods and compositions | |
| GB201514415D0 (en) | Compositions and methods |